Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 341 entries
View as:

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT07010120 Org: User:
Start: 06/10/25 End: 05/31/27 Due: 05/31/28

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06394427 Org: User:
Start: 05/31/24 End: 08/31/25 Due: 08/31/26

Primary Prophylaxis of Gastric Variceal Bleed

Phase: N/A Priority: Normal
NCT ID: NCT02468180 Org: User:
Start: 06/30/15 End: 07/31/22 Due: 07/31/23

Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture

Phase: N/A Priority: Normal
NCT ID: NCT06728033 Org: User:
Start: 01/01/25 End: 12/31/27 Due: 12/31/28

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02313688 Org: User:
Start: 01/31/15 End: 12/31/23 Due: 12/31/24

Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy

Phase: N/A Priority: Normal
NCT ID: NCT05662813 Org: User:
Start: 11/09/22 End: 06/30/25 Due: 06/30/26

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Phase: N/A Priority: Normal
NCT ID: NCT07020247 Org: User:
Start: 11/19/24 End: 01/31/28 Due: 01/31/29

Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06349967 Org: User:
Start: 04/30/24 End: 05/30/27 Due: 05/30/28

Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT03356444 Org: User:
Start: 11/30/17 End: 12/31/20 Due: 12/31/21

Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points

Phase: N/A Priority: Normal
NCT ID: NCT03299439 Org: User:
Start: 10/25/17 End: 11/20/20 Due: 11/20/21

The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM

Phase: N/A Priority: Normal
NCT ID: NCT02648685 Org: User:
Start: 11/30/15 End: 12/31/19 Due: 12/31/20

Efficacy and Safety of Sirolimus to Vascular Anomalies

Phase: N/A Priority: Normal
NCT ID: NCT03583307 Org: User:
Start: 06/01/18 End: 02/19/21 Due: 02/19/22

Efficacy of the Integration of Digital Therapeutics and Home-based Cardiac Rehabilitation in High-Risk Post-PCI Patients

Phase: N/A Priority: Normal
NCT ID: NCT06542575 Org: User:
Start: 12/04/24 End: 05/31/26 Due: 05/31/27

Sintilimab in FH-deficient Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04146831 Org: User:
Start: 06/01/20 End: 04/01/23 Due: 04/01/24

Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04450888 Org: User:
Start: 07/01/20 End: 01/22/22 Due: 01/22/23

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Phase: N/A Priority: Normal
NCT ID: NCT06664996 Org: User:
Start: 10/15/24 End: 10/31/26 Due: 10/31/27

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06667050 Org: User:
Start: 10/10/24 End: 10/31/27 Due: 10/31/28

Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04865705 Org: User:
Start: 11/10/20 End: 06/10/22 Due: 06/10/23

Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS

Phase: N/A Priority: Normal
NCT ID: NCT03933891 Org: User:
Start: 08/28/18 End: 05/30/25 Due: 05/30/26

Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06132698 Org: User:
Start: 11/30/23 End: 11/30/25 Due: 11/30/26

Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT06406244 Org: User:
Start: 04/20/24 End: 10/20/26 Due: 10/20/27

PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT06742424 Org: User:
Start: 10/01/24 End: 07/30/27 Due: 07/30/28

Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04922853 Org: User:
Start: 08/26/21 End: 12/01/26 Due: 12/01/27

Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT06341270 Org: User:
Start: 05/06/24 End: 12/20/26 Due: 12/20/27

Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT04736108 Org: User:
Start: 05/31/21 End: 12/31/24 Due: 12/31/25